<DOC>
	<DOCNO>NCT00337662</DOCNO>
	<brief_summary>The current study design address significance early onset response prospectively patient treat atypical antipsychotic .</brief_summary>
	<brief_title>Efficacy Study Early Onset Antipsychotic Drug Action Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Patients must demonstrate acute psychopathologic severity criterion least moderately ill . Patients must experience exacerbation illness within previous 2 week . Patients switch another antipsychotic medication acutely indicate . Patients deem nonresponsive risperidone olanzapine . Patients hospitalize great 2 week immediately prior Visit 1 . Patients receive olanzapine risperidone past 30 day . Treatment clozapine within 1 year prior Visit 1 . Diagnosis substanceinduced psychosis Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) criterion within 7 day Visit 1 ( time study ) , confirm clinical ground within 72 hour subsequent Visit 1 ( time study ) . A diagnosis Parkinson 's disease , dementiarelated psychosis , related disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>